Start Trading Now

Track, analyse global markets and share your insight

or continue with e-mail and password
Don't have an account?

Supercharge Your Portfolio

Join the #1 Retail Trader Community

or continue with e-mail and password

By signing up, you agree to our Terms & Privacy Policy

Already have an account?
ESC
Browse
Trending
↑↓navigate↵selectesccloseCtrl+Ssearch
tech-scienceKXFDAAPPROVALDATECMPSOpen

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?

kalshiView on kalshiAdded Apr 17, 2026
YesBuy Yes
32¢
32% implied probability
NoBuy No
68¢
68% implied probability
Volume$4.0K
Liquidity—
Open Interest$2.0K
ExpiresJul 1, 2027
Yes Price$0.32
No Price$0.68
ResolvedPending
OutcomePending

Probability Distribution

Yes 32%
68% No

Description

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.

Market Details

ID6454
Platformkalshi
Categorytech-science
SubcategoryKXFDAAPPROVALDATECMPS
StatusOpen
CreatedApr 17, 2026
ExpiresJul 1, 2027
Resolved—